Fresenius Medical Care AG (NYSE:FMS) is one of the 13 Best German Stocks to Invest in Now. On July 3, the company announced it had partnered with Mexico’s Coordination of National Institutes of ...

Fresenius Kabi’s fifth and sixth biosimilars Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht) have launched in the United States for all approved indications.

Fresenius announced today that its operating company Fresenius Kabi, has introduced two new biosimilars - Conexxence® (denosumab-bnht) and Bomyntra® (denosumab-bnht) - in the United States. This ...

Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients ...

(RTTNews) - Fresenius Medical Care AG (FMG) on Tuesday unveiled its FME Reignite strategy at its Capital Markets Day in London, outlining a roadmap for value creation through three pillars, namely ...

Get the latest Fresenius Medical Care AG (FMS) stock news and headlines to help you in your trading and investing decisions.

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs. The partnership expands Vifor Pharma’s cooperation with Fresenius ...

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi.

Mariage Frères’ Summer Rosé® iced tea is a vibrant pink white tea from their Jardin Premier® collection, bursting with sunny notes of red fruits, grape, bergamot, and pomegranate. Refreshing ...